2022
DOI: 10.1016/j.bios.2022.114631
|View full text |Cite
|
Sign up to set email alerts
|

Label-free, ultrasensitive and rapid detection of FDA-approved TBI specific UCHL1 biomarker in plasma using MWCNT-PPY nanocomposite as bio-electrical transducer: A step closer to point-of-care diagnosis of TBI

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 11 publications
references
References 65 publications
0
0
0
Order By: Relevance